Enhanced Prediction of HER2 Status in Breast Cancer through the Integration of Intratumoral and Peritumoral Radiomic Features from DCE-MRI - Scorecard - MDSpire

Enhanced Prediction of HER2 Status in Breast Cancer through the Integration of Intratumoral and Peritumoral Radiomic Features from DCE-MRI

  • By

  • Yang Gao

  • Jiangnian Gong

  • Yuanling Yang

  • Yingyi Luo

  • Weiyi Liu

  • Zisan Zeng

  • February 13, 2026

  • 0 min

Share

Clinical Scorecard: Enhanced Prediction of HER2 Status in Breast Cancer through the Integration of Intratumoral and Peritumoral Radiomic Features from DCE-MRI

At a Glance

CategoryDetail
Condition
Key MechanismsHER2 promotes cancer cell proliferation, invasion, and survival through specific signaling pathways, particularly in HER2-low subtypes.
Target Population
Care Setting

Key Highlights

  • The study developed a predictive model using intratumoral and peritumoral radiomic features.

Guideline-Based Recommendations

Diagnosis

    Management

      Monitoring & Follow-up

        Risks

        • I
        • n
        • v
        • a
        • s
        • i
        • v
        • e
        • t
        • e
        • s
        • t
        • i
        • n
        • g
        • m
        • e
        • t
        • h
        • o
        • d
        • s
        • m
        • a
        • y
        • u
        • n
        • d
        • e
        • r
        • -
        • d
        • e
        • t
        • e
        • c
        • t
        • H
        • E
        • R
        • 2
        • -
        • l
        • o
        • w
        • e
        • x
        • p
        • r
        • e
        • s
        • s
        • i
        • o
        • n
        • d
        • u
        • e
        • t
        • o
        • t
        • u
        • m
        • o
        • r
        • h
        • e
        • t
        • e
        • r
        • o
        • g
        • e
        • n
        • e
        • i
        • t
        • y
        • ,
        • p
        • o
        • t
        • e
        • n
        • t
        • i
        • a
        • l
        • l
        • y
        • l
        • e
        • a
        • d
        • i
        • n
        • g
        • t
        • o
        • i
        • n
        • a
        • d
        • e
        • q
        • u
        • a
        • t
        • e
        • t
        • r
        • e
        • a
        • t
        • m
        • e
        • n
        • t
        • .

        Patient & Prescribing Data

        Female patients with confirmed breast cancer and available clinical records.

        Novel ADCs show improved survival outcomes in HER2-low breast cancer.

        Clinical Best Practices

        • Integrate radiomic features into clinical assessments for improved HER2 status evaluation.

        References

        Original Source(s)

        Related Content